ATA13590A - Pharmazeutische zusammensetzung enthaltend einen ace-inhibitor in kombination mit hydrochlorothiazid - Google Patents
Pharmazeutische zusammensetzung enthaltend einen ace-inhibitor in kombination mit hydrochlorothiazidInfo
- Publication number
- ATA13590A ATA13590A AT0013590A AT13590A ATA13590A AT A13590 A ATA13590 A AT A13590A AT 0013590 A AT0013590 A AT 0013590A AT 13590 A AT13590 A AT 13590A AT A13590 A ATA13590 A AT A13590A
- Authority
- AT
- Austria
- Prior art keywords
- hydrochlorothiazide
- combination
- pharmaceutical composition
- composition containing
- ace inhibitor
- Prior art date
Links
- 239000005541 ACE inhibitor Substances 0.000 title 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 title 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 title 1
- 229960002003 hydrochlorothiazide Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30038389A | 1989-01-23 | 1989-01-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA13590A true ATA13590A (de) | 1996-04-15 |
| AT401728B AT401728B (de) | 1996-11-25 |
Family
ID=23158879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0013590A AT401728B (de) | 1989-01-23 | 1990-01-22 | Pharmazeutische zusammensetzung enthaltend einen ace-inhibitor in kombination mit hydrochlorothiazid |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JP3009694B2 (de) |
| KR (1) | KR0141479B1 (de) |
| AT (1) | AT401728B (de) |
| AU (1) | AU629288B2 (de) |
| BE (1) | BE1002736A4 (de) |
| CA (1) | CA2008126C (de) |
| CH (1) | CH680568A5 (de) |
| CY (1) | CY1835A (de) |
| DE (2) | DE10199041I1 (de) |
| DK (1) | DK175204B1 (de) |
| FR (1) | FR2641971B1 (de) |
| GB (1) | GB2227172B (de) |
| HK (1) | HK98995A (de) |
| IE (1) | IE61784B1 (de) |
| IL (1) | IL93117A0 (de) |
| IT (1) | IT1239744B (de) |
| LU (1) | LU87660A1 (de) |
| MX (1) | MX9203362A (de) |
| NL (1) | NL194958C (de) |
| NZ (1) | NZ232182A (de) |
| SA (1) | SA90100151B1 (de) |
| SE (1) | SE506179C2 (de) |
| SG (1) | SG176194G (de) |
| ZA (1) | ZA90429B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100221695B1 (ko) * | 1991-08-12 | 1999-09-15 | 그린 마틴, 브라이언 쥐 테슬리 | 약학적 구상 제형 |
| DK9200258U4 (da) * | 1992-03-11 | 1993-07-23 | Merck & Co Inc | Farmaceutisk præparat indeholdende enalapril til brug mod hypertension |
| GB9613470D0 (en) | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
| CN102579346B (zh) * | 2012-03-02 | 2013-09-25 | 海南美兰史克制药有限公司 | 贝那普利/氢氯噻嗪药物组合物脂质体固体制剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217347A (en) * | 1977-12-27 | 1980-08-12 | E. R. Squibb & Sons, Inc. | Method of treating hypertension and medicaments therefor |
| IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
| US4410520A (en) * | 1981-11-09 | 1983-10-18 | Ciba-Geigy Corporation | 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids |
| ZA833903B (en) * | 1982-06-01 | 1984-11-28 | Merck & Co Inc | Benzofused lactams as antihypertensives |
| US4520021A (en) * | 1982-07-02 | 1985-05-28 | Merck & Co., Inc. | Substituted caprolactam derivatives as antihypertensives |
-
1990
- 1990-01-08 SE SE9000050A patent/SE506179C2/sv not_active IP Right Cessation
- 1990-01-15 CH CH112/90A patent/CH680568A5/de not_active IP Right Cessation
- 1990-01-17 GB GB9001054A patent/GB2227172B/en not_active Expired - Lifetime
- 1990-01-18 LU LU87660A patent/LU87660A1/de unknown
- 1990-01-19 DE DE2001199041 patent/DE10199041I1/de active Pending
- 1990-01-19 DE DE4001496A patent/DE4001496C2/de not_active Expired - Lifetime
- 1990-01-19 NZ NZ232182A patent/NZ232182A/en unknown
- 1990-01-19 IT IT47548A patent/IT1239744B/it active IP Right Grant
- 1990-01-19 FR FR909000612A patent/FR2641971B1/fr not_active Expired - Lifetime
- 1990-01-19 CA CA002008126A patent/CA2008126C/en not_active Expired - Lifetime
- 1990-01-22 KR KR1019900000697A patent/KR0141479B1/ko not_active Expired - Lifetime
- 1990-01-22 ZA ZA90429A patent/ZA90429B/xx unknown
- 1990-01-22 AT AT0013590A patent/AT401728B/de not_active IP Right Cessation
- 1990-01-22 BE BE9000074A patent/BE1002736A4/fr not_active IP Right Cessation
- 1990-01-22 NL NL9000158A patent/NL194958C/nl not_active IP Right Cessation
- 1990-01-22 IE IE23390A patent/IE61784B1/en not_active IP Right Cessation
- 1990-01-22 AU AU48703/90A patent/AU629288B2/en not_active Expired
- 1990-01-22 DK DK199000174A patent/DK175204B1/da not_active IP Right Cessation
- 1990-01-22 IL IL93117A patent/IL93117A0/xx not_active IP Right Cessation
- 1990-01-22 JP JP2010782A patent/JP3009694B2/ja not_active Expired - Lifetime
- 1990-04-04 SA SA90100151A patent/SA90100151B1/ar unknown
-
1992
- 1992-06-25 MX MX9203362A patent/MX9203362A/es unknown
-
1994
- 1994-12-16 SG SG176194A patent/SG176194G/en unknown
-
1995
- 1995-06-22 HK HK98995A patent/HK98995A/xx not_active IP Right Cessation
- 1995-12-01 CY CY183595A patent/CY1835A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA129892A (de) | Pharmazeutische zusammensetzung | |
| DE122004000023I2 (de) | Pharmazeutische Zusammensetzung | |
| DE68901417D1 (de) | Pharmazeutische zusammensetzung. | |
| DE69233474D1 (de) | Pharmazeutische Zusammensetzung enthaltend S-Nitrosoimmunoglobuline und Verwendung davon | |
| FI943569L (fi) | Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia | |
| DE4291156T1 (de) | Verbesserte pharmazeutische Zusammensetzungen | |
| DE69810612D1 (de) | Pharmazeutische Zusammensetzungen mit Plasmaproteinen | |
| FR2713981B1 (fr) | Matériau absorbant et article d'hygiène intime l'incorporant. | |
| DE69101931D1 (de) | Pharmazeutische Zusammensetzung. | |
| EP0265685A3 (en) | Combination of ace inhibitors with calcium antagonists, and their use in medicines | |
| DE3879811D1 (de) | Pharmazeutische zusammensetzung und ihre verwendung. | |
| NZ233122A (en) | Synergistic pharmaceutical composition comprising ketanserine and an ace inhibitor | |
| DE69522188D1 (de) | Verwendung von Substanz P Antagonist im pharmazeutischer Zusammensetzung | |
| DE68918847D1 (de) | Stabile pharmazeutische zusammensetzung. | |
| FI941361A7 (fi) | Läpinäkyvä kopolyamidi ja sen käyttö sulkukerroksiin | |
| FI925418L (fi) | Polyesterhartser med hoeg molekylmassa och med laog smaeltpunkt | |
| DE69434210D1 (de) | Pharmazeutische antacidzusammensetzung | |
| DK0397175T3 (da) | Substituerede pyrrolizinforbindelser og deres anvendelse inden for farmacien | |
| DE69013557D1 (de) | An Liposome gekuppelte bioaktive Verbindungen und ihre Verwendung in pharmazeutischen Zubereitungen. | |
| ATA147691A (de) | Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung | |
| ATA13590A (de) | Pharmazeutische zusammensetzung enthaltend einen ace-inhibitor in kombination mit hydrochlorothiazid | |
| IT1234194B (it) | Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione | |
| FI930293A7 (fi) | Uusia heteroaryylioksi-b-karboliineja, niiden valmistus ja käyttö lääk keissä | |
| DE69012031D1 (de) | Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung. | |
| DE68915203D1 (de) | Pharmazeutische Mischungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee | ||
| ELA | Expired due to lapse of time |